Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Decitabine

EU orphan designation number: EU/3/03/135   
Active ingredient: Decitabine
Indication: Treatment of myelodysplastic syndromes
Sponsor: Janssen-Cilag International NV
Turnhoutseweg 30, 2340 Beerse, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/02/2003 Orphan designation EMEA/OD/059/02 (2003)592 of 14/02/2003
28/03/2006 Transfer of orphan designation EMEA/OD/059/02/T/01 (2006)1044 of 22/03/2006
01/09/2006 Change of name and/or address of sponsor
27/03/2007 Transfer of orphan designation EMEA/OD/059/02/T/02 (2007)1447 of 23/03/2007